Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 19,891 | 10,000 | 1,534 | 0 | 3 |
| Gross Profit | 19,891 | 10,000 | 1,534 | N/A | 3 |
| Operating Expenses | 54,223 | 48,942 | 40,986 | 31,055 | 29,755 |
| Operating Income | -34,332 | -38,942 | -39,452 | -31,055 | -29,752 |
| Other Income | 660 | 495 | 421 | 428 | 383 |
| Pre-tax Income | -33,672 | -38,447 | -39,031 | -30,627 | -29,369 |
| Income Tax | -17 | 12 | 9 | 13 | 18 |
| Net Income Continuous | -33,655 | -38,459 | -39,040 | -30,640 | -29,387 |
| Net Income | $-33,655 | $-38,459 | $-39,040 | $-30,640 | $-29,387 |
| EPS Basic Total Ops | -9.00 | -11.69 | -12.14 | -9.75 | -9.60 |
| EPS Basic Continuous Ops | -9.00 | -11.62 | -12.07 | -9.74 | -9.61 |
| EPS Diluted Total Ops | -9.00 | -11.69 | -12.14 | -9.75 | -9.60 |
| EPS Diluted Continuous Ops | -9.00 | -11.62 | -12.07 | -9.74 | -9.61 |
| EBITDA(a) | $-34,038 | $-38,613 | $-38,994 | $-30,568 | $-29,247 |